Efficacy and Genomic Analysis of <i>HER2</i> -Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial

Komal Jhaveri, Lisa D. Eli, Sara A. Hurvitz, Adam Brufsky, Ron Bose, María de Miguel, Nisha Unni, Sonya Reid, David I. Quinn, Devalingam Mahalingam, Cristina Saura Manich, José Ángel García-Sáenz, Alejandro Martínez-Bueno, Angel Guerrero-Zotano, Olivier Trédan, Hans Wildiers, Georg F. Bischof, Judith Bebchuk, David B. Solit

Open source

DOI: 10.1158/1078-0432.ccr-25-4135
Published: 2026-04-06
Container: Clinical Cancer Research
Publisher: American Association for Cancer Research (AACR)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-25-4135,
  title = {Efficacy and Genomic Analysis of
                    <i>HER2</i>
                    -Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial},
  author = {Komal Jhaveri and Lisa D. Eli and Sara A. Hurvitz and Adam Brufsky and Ron Bose and María de Miguel and Nisha Unni and Sonya Reid and David I. Quinn and Devalingam Mahalingam and Cristina Saura Manich and José Ángel García-Sáenz and Alejandro Martínez-Bueno and Angel Guerrero-Zotano and Olivier Trédan and Hans Wildiers and Georg F. Bischof and Judith Bebchuk and David B. Solit},
  year = {2026},
  journal = {Clinical Cancer Research},
  doi = {10.1158/1078-0432.ccr-25-4135},
  url = {https://doi.org/10.1158/1078-0432.ccr-25-4135}
}

RIS

TY  - JOUR
TI  - Efficacy and Genomic Analysis of
                    <i>HER2</i>
                    -Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial
AU  - Komal Jhaveri
AU  - Lisa D. Eli
AU  - Sara A. Hurvitz
AU  - Adam Brufsky
AU  - Ron Bose
AU  - María de Miguel
AU  - Nisha Unni
AU  - Sonya Reid
AU  - David I. Quinn
AU  - Devalingam Mahalingam
AU  - Cristina Saura Manich
AU  - José Ángel García-Sáenz
AU  - Alejandro Martínez-Bueno
AU  - Angel Guerrero-Zotano
AU  - Olivier Trédan
AU  - Hans Wildiers
AU  - Georg F. Bischof
AU  - Judith Bebchuk
AU  - David B. Solit
PY  - 2026
JO  - Clinical Cancer Research
DO  - 10.1158/1078-0432.ccr-25-4135
UR  - https://doi.org/10.1158/1078-0432.ccr-25-4135
ER  -

APA

Jhaveri, K., Eli, L. D., Hurvitz, S. A., Brufsky, A., Bose, R., Miguel, M. D., Unni, N., Reid, S., Quinn, D. I., Mahalingam, D., Manich, C. S., García-Sáenz, J. Á., Martínez-Bueno, A., Guerrero-Zotano, A., Trédan, O., Wildiers, H., Bischof, G. F., Bebchuk, J., & Solit, D. B. (2026). Efficacy and Genomic Analysis of <i>HER2</i> -Mutant Metastatic Triple-Negative Breast Cancer Treated with Neratinib Alone or with Trastuzumab in the SUMMIT Basket Trial. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-25-4135

Source records

crossref · retrieved 2026-09-26T05:37:07.851Z